Learn more by exploring our library of videos, webinars, publications and more.
Yes. Brachytherapy for the treatment of intracranial malignancies holds tremendous promise for optimal management of these frequently complex patients. – Drs. Weinberg and Beckham
No. The role of brachytherapy for malignant gliomas has been well investigated and found to confer no survival benefit for patients when combined with best surgical resection and standard external radiotherapy. – Dr. Barnett
Dr. Kotecha: Radiation therapy can be delivered to the brain externally through machines, which is called external beam radiation therapy. This is the most common approach or use in radiation therapy and some terms that you may hear that are using this type of treatment are stereotactic radiosurgery. An alternative means of delivering radiation therapy is when radiation is actually implanted into the brain itself, and that is called brachytherapy.
Neuro-Oncology Advances 2021 | Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas [published online December 27, 2021]. https://doi.org/10.1093/noajnl/vdab185
During these uncertain times, remember to proactively reach out to patients and encourage them to resume routine cancer screenings to prevent delayed diagnoses that might lead to worsened health outcomes.
Matt Likens describes GammaTile Therapy, GT Medical Technologies’ mission, and how working with Silicon Valley Bank has helped GT Medical achieve their purpose of improving the lives of patients with brain tumors.
Orange Park Medical Center is the first hospital in North Florida to provide a new brain tumor treatment the size of a computer chip.
Brachytherapy 2021 | Shearwood McClelland, Ulysses G Gardner, Yi Le, Sook Kien Ng, Mitesh V Shah, Gordon A Watson. Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy [published online September 26, 2021]. Brachytherapy. doi.org/10.1016/j.brachy.2021.08.011.
GammaTile Therapy Physician Perspective | Multi-Disciplinary Brain Tumor Treatment Team at Mayfield Brain & Spine
Physicians from the multi-disciplinary brain tumor treatment team at Mayfield Brain & Spine share their experiences with GammaTile Therapy
GammaTile Therapy Patient & Physician Perspective | Mary, Glioblastoma Survivor, and her Physician Team at Mayfield Brain & Spine
Mary, a patient with glioblastoma treated with GammaTile Therapy, and her husband and treating cancer team, share their experiences
GammaTile Therapy Patient & Physician Perspective | Robert, Brain Metastases Survivor, and his Physician Team at the Piedmont Brain Tumor Center
Robert, a patient with brain metastases treated with GammaTile Therapy, and his treating cancer team, share their experiences
GammaTile Therapy Physician Perspective | Multi-Disciplinary Brain Tumor Treatment Team at the Piedmont Brain Tumor Center
Physicians from the multi-disciplinary brain tumor treatment team at the Piedmont Brain Tumor Center share their experiences with GammaTile Therapy
A Neurosurgeon’s Perspective On The Early Clinical Experience With GammaTile Therapy At An NCI-Designated Cancer Center
Dr. Kimberly Bojanowski Hoang of Emory University describes their experience with GammaTile Therapy, including a product overview, patient selection criteria, procedural workflow, and early clinical outcomes.
GammaTile® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. For full product and safety information, refer to the Instructions for Use.